According to BioIntel360, Middle East and Africa biosimilar market size is expected to record a CAGR of 4.4% during 2023-2027 to reach US$1,168.2 million by 2027, increasing from US$954.7 million in 2...
According to BioIntel360, Middle East and Africa biosimilar market size is expected to record a CAGR of 4.4% during 2023-2027 to reach US$1,168.2 million by 2027, increasing from US$954.7 million in 2023. Over the last five years, the sector has recorded a CAGR of 4.4% to reach US$914.8 million in 2022. This offering from BioIntel360 is a bundled offering, combining 4 countries and a key report covering Middle East and Africa region. This report provides an in-depth data-centric analysis of the emerging opportunities in the biosimilar industry. It covers a detailed view of market size and forecast across various segments such as by product, type of cell, imaging technique, procedure, source of manufacturing, applications, type of technology, and end users in Middle East and Africa region. This title from BioIntel360 is a bundled offering, combining the following 5 reports, covering 178+ tables and 207+ figures: Country Report 1 - Middle East & Africa Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update Country Report 2 - Israel Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update Country Report 3 -South Africa Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update Country Report 4 -Saudi Arabia Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update Country Report 5 -Turkey Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update
This report provides an in-depth, data-centric analysis of the Middle East & Africa biosimilar market 2018-2027. Below is a summary of key market segments: Biosimilar Market Size By Product • Monoclonal Antibody Biosimilars • Insulin Biosimilar • Biosimilar Interferons • Other Biosimilar Biosimilar Market Size By Type of Cell • Mammalian • Non-Mammalian Biosimilar Market Size By Imaging Technique • Magnetic Resonance Imaging Scanners • Computed Tomography Scanners • Positron Emission Tomography Scanners • Others Biosimilar Market Size By Procedure • Invasive • Non-Invasive Biosimilar Market Size By Source of Manufacturing • In-House • Contract Manufacturing Biosimilar Market Size By Applications • Oncology • Blood Disorders • Growth Hormonal Deficiency • Chronic & Autoimmune Disorders • Infectious Diseases • Others Biosimilar Market Size By Type of Technology • Mass Spectroscopy • Chromatography • Recombinant DNA technology • Electrophoresis • Others Biosimilar Market Size By End User • Hospital & Clinics • Diagnostic Centres • Others
• In-depth understanding of biosimilars market dynamics: Understand market opportunity, industry dynamics, key trends and drivers across different market segments and sub-segments of the industry in Middle East & Africa. • Develop market-specific strategies: Identify growth segments and target specific opportunities to formulate your investment strategy; assess market-specific key trends, drivers, and risks in the industry. • Get market share analysis by end users: Get a detailed analysis across different end users such as hospitals & clinics, diagnostic centres within the Middle East & Africa.
This title from BioIntel360 is a bundled offering, combining the following 4 reports, covering 149+ tables and 166+ figures: Country Report 1 - Latin America Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update Country Report 2 - Brazil Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update Country Report 3 -Argentina Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update Country Report 4 -Colombia Biosimilars Business and Investment Opportunities Databook – Q2 2023 Update 1 About this Report 1.1 Research Methodology 1.2 Disclaimer 2 Biosimilar Market Size and Forecast, 2018-2027 3 Biosimilar Market Share by Product, 2018-2027 3.1 Biosimilar Market Size by Monoclonal Antibody Biosimilars, 2018-2027 3.2 Biosimilar Market Size by Insulin Biosimilar, 2018-2027 3.3 Biosimilar Market Size by Biosimilar Interferons, 2018-2027 3.4 Biosimilar Market Size by Other Biosimilars, 2018-2027 4 Biosimilar Market Share by Monoclonal Antibody Biosimilars, 2018-2027 5 Biosimilar Market Share by Insulin Biosimilars, 2018-2027 6 Biosimilar Market Share by Interferons Biosimilars, 2018-2027 7 Biosimilar Market Share by Other Biosimilars, 2018-2027 8 Biosimilar Market Share by Type of Cell, 2018-2027 8.1 Biosimilar Market Size by Mammalian Cell, 2018-2027 8.2 Biosimilar Market Size by Non-Mammalian Cell, 2018-2027 9 Biosimilar Market Share by Imaging Technique, 2018-2027 9.1 Biosimilar Market Size by Magnetic Resonance Imaging Scanners, 2018-2027 9.2 Biosimilar Market Size by Computed Tomography Scanners, 2018-2027 9.3 Biosimilar Market Size by Positron Emission Tomography Scanners, 2018-2027 9.4 Biosimilar Market Size by Others, 2018-2027 10 Biosimilar Market Share by Procedure, 2018-2027 10.1 Biosimilar Market Size by Invasive Procedure, 2018-2027 10.2 Biosimilar Market Size by Non-Invasive Procedure, 2018-2027 11 Biosimilar Market Share by Source of Manufacturing, 2018-2027 11.1 Biosimilar Market Size by In-House, 2018-2027 11.2 Biosimilar Market Size by Contract Manufacturing, 2018-2027 12 Biosimilar Market Share by Applications, 2018-2027 12.1 Biosimilar Market Size by Oncology, 2018-2027 12.2 Biosimilar Market Size by Blood Disorders, 2018-2027 12.3 Biosimilar Market Size by Growth Hormonal Deficiency, 2018-2027 12.4 Biosimilar Market Size by Chronic & Autoimmune Disorders, 2018-2027 12.5 Biosimilar Market Size by Infectious Diseases, 2018-2027 12.6 Biosimilar Market Size by Others, 2018-2027 13 Biosimilar Market Share by Type of Technology, 2018-2027 13.1 Biosimilar Market Size by Mass Spectroscopy, 2018-2027 13.2 Biosimilar Market Size by Chromatography, 2018-2027 13.3 Biosimilar Market Size by Recombinant DNA Technology, 2018-2027 13.4 Biosimilar Market Size by Electrophoresis, 2018-2027 13.5 Biosimilar Market Size by Others, 2018-2027 14 Biosimilar Market Share by End User, 2018-2027 14.1 Biosimilar Market Size by Hospital & Clinics, 2018-2027 14.2 Biosimilar Market Size by Diagnostic Centres, 2018-2027 14.3 Biosimilar Market Size by Others, 2018-2027 15 Further Reading 15.1 About BioIntel360 15.2 Related Research 15.3 Consulting
Table 1: Biosimilar Market Size by Value (USD MM) 2018-2027 Table 2: Biosimilar Market Size by Monoclonal Antibody Biosimilars, by Value (USD MM), 2018-2027 Table 3: Biosimilar Market Size by Insulin Biosimilar, by Value (USD MM) 2018-2027 Table 4: Biosimilar Market Size by Biosimilar Interferons, by Value (USD MM) 2018-2027 Table 5: Biosimilar Market Size by Other Biosimilars, by Value (USD MM) 2018-2027 Table 6: Biosimilar Market Size by Mammalian Cell, by Value (UDS MM) 2018-2027 Table 7: Biosimilar Market Size by Non-Mammalian Cell, by Value (UDS MM) 2018-2027 Table 8: Biosimilar Market Size by Magnetic Resonance Imaging Scanners, by Value (USD MM), 2018-2027 Table 9: Biosimilar Market Size by Computed Tomography Scanners, by Value (USD MM), 2018-2027 Table 10: Biosimilar Market Size by Positron Emission Tomography Scanners, by Value (USD MM), 2018-2027 Table 11: Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Table 12: Biosimilar Market Size by Invasive Procedure (USD MM), 2018-2027 Table 13: Biosimilar Market Size by Non-Invasive Procedure (USD MM), 2018-2027 Table 14: Biosimilar Market Size by In-House, by Value (USD MM), 2018-2027 Table 15: Biosimilar Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 Table 16: Biosimilar Market Size by Oncology, by Value (USD MM), 2018-2027 Table 17: Biosimilar Market Size by Blood Disorders, by Value (USD MM), 2018-2027 Table 18: Biosimilar Market Size by Growth Hormonal Deficiency, by Value (USD MM), 2018-2027 Table 19: Biosimilar Market Size by Chronic & Autoimmune Disorders, by Value (USD MM), 2018-2027 Table 20: Biosimilar Market Size by Infectious Diseases, by Value (USD MM), 2018-2027 Table 21: Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Table 22: Biosimilar Market Size by Mass Spectroscopy, by Value (USD MM), 2018-2027 Table 23: Biosimilar Market Size by Chromatography, by Value (USD MM), 2018-2027 Table 24: Biosimilar Market Size by Recombinant DNA Technology, by Value (USD MM), 2018-2027 Table 25: Biosimilar Market Size by Electrophoresis, by Value (USD MM), 2018-2027 Table 26: Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Table 27: Biosimilar Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027 Table 28: Biosimilar Market Size by Diagnostic Centres, by Value (USD MM), 2018-2027 Table 29: Biosimilar Market Size by Others, by Value (USD MM), 2018-2027
Figure 1: Biosimilar Market Size by Value (USD MM) 2018-2027 Figure 2: Biosimilar Market Share by Product (%), 2018-2027 Figure 3: Biosimilar Market Size by Monoclonal Antibody Biosimilars, by Value (USD MM), 2018-2027 Figure 4: Biosimilar Market Size by Insulin Biosimilar, by Value (USD MM) 2018-2027 Figure 5: Biosimilar Market Size by Biosimilar Interferons, by Value (USD MM) 2018-2027 Figure 6: Biosimilar Market Size by Other Biosimilars, by Value (USD MM) 2018-2027 Figure 7: Biosimilar Market Share Monoclonal Antibody Biosimilars (%), 2018-2027 Figure 8: Biosimilar Market Share by Insulin Biosimilars (%), 2018-2027 Figure 9: Biosimilar Market Share by Interferons Biosimilars (%), 2018-2027 Figure 10: Biosimilar Market Share by Other Biosimilars (%), 2018-2027 Figure 11: Biosimilar Market Share by Type of Cell (%), 2018-2027 Figure 12: Biosimilar Market Share by Mammalian Cell, by Value (UDS MM) 2018-2027 Figure 13: Biosimilar Market Share by Non-Mammalian Cell, by Value (UDS MM) 2018-2027 Figure 14: Biosimilar Market Share by Imaging Technique (%), 2018-2027 Figure 15: Biosimilar Market Size by Magnetic Resonance Imaging Scanners, by Value (USD MM), 2018-2027 Figure 16: Biosimilar Market Size by Computed Tomography Scanners, by Value (USD MM), 2018-2027 Figure 17: Biosimilar Market Size by Positron Emission Tomography Scanners, by Value (USD MM), 2018-2027 Figure 18: Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Figure 19: Biosimilar Market Share by Procedure (%), 2018-2027 Figure 20: Biosimilar Market Size by Invasive Procedure (USD MM), 2018-2027 Figure 21: Biosimilar Market Size by Non-Invasive Procedure (USD MM), 2018-2027 Figure 22: Biosimilar Market Share by Source of Manufacturing (%), 2018-2027 Figure 23: Biosimilar Market Size by In-House, by Value (USD MM), 2018-2027 Figure 24: Biosimilar Market Size by Contract Manufacturing, by Value (USD MM), 2018-2027 Figure 25: Biosimilar Market Share by Applications (%), 2018-2027 Figure 26: Biosimilar Market Size by Oncology, by Value (USD MM), 2018-2027 Figure 27: Biosimilar Market Size by Blood Disorders, by Value (USD MM), 2018-2027 Figure 28: Biosimilar Market Size by Growth Hormonal Deficiency, by Value (USD MM), 2018-2027 Figure 29: Biosimilar Market Size by Chronic & Autoimmune Disorders, by Value (USD MM), 2018-2027 Figure 30: Biosimilar Market Size by Infectious Diseases, by Value (USD MM), 2018-2027 Figure 31: Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Figure 32: Biosimilar Market Share by Type of Technology (%), 2018-2027 Figure 33: Biosimilar Market Size by Mass Spectroscopy, by Value (USD MM), 2018-2027 Figure 34: Biosimilar Market Size by Chromatography, by Value (USD MM), 2018-2027 Figure 35: Biosimilar Market Size by Recombinant DNA Technology, by Value (USD MM), 2018-2027 Figure 36: Biosimilar Market Size by Electrophoresis, by Value (USD MM), 2018-2027 Figure 37: Biosimilar Market Size by Others, by Value (USD MM), 2018-2027 Figure 38: Biosimilar Market Share by End User (%), 2018-2027 Figure 39: Biosimilar Market Size by Hospital & Clinics, by Value (USD MM), 2018-2027 Figure 40: Biosimilar Market Size by Diagnostic Centres, by Value (USD MM), 2018-2027 Figure 41: Biosimilar Market Size by Others, by Value (USD MM), 2018-2027
